Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pola Day is a professional-grade, at-home dental whitening system developed and manufactured by SDI (Southern Dental Industries). The product is formulated as a pH-neutral gel containing hydrogen peroxide (HP) as its primary active ingredient, typically in concentrations ranging from 3% to 9.5%. Pola Day works through an oxidation mechanism where hydrogen peroxide releases reactive oxygen species that penetrate the tooth's enamel and dentin to break down large, dark-colored organic chromogens into smaller, lighter-colored molecules. The formulation is designed for use in customized dental trays and often incorporates high water content and desensitizing agents, such as fluoride or potassium nitrate, to minimize common side effects like tooth sensitivity and enamel demineralization during the bleaching process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pola Day.